Will the large-scale vaccination succeed in containing the COVID-19 pandemic and how soon?

被引:0
|
作者
Shilei Zhao [1 ,2 ,3 ]
Tong Sha [1 ,2 ,3 ]
ChungI Wu [1 ,4 ,5 ]
Yongbiao Xue [1 ,2 ,3 ]
Hua Chen [1 ,2 ,3 ,6 ]
机构
[1] Beijing Institute of Genomics, Chinese Academy of Sciences
[2] China National Center for Bioinformation
[3] School of Future Technology, University of Chinese Academy of Sciences
[4] State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University
[5] Department of Ecology and Evolution, University of Chicago
[6] CAS Center for Excellence in Animal Evolution and Genetics, Chinese Academy of
关键词
D O I
暂无
中图分类号
R511 [病毒传染病]; R186 [预防接种、计划免疫、药物预防];
学科分类号
摘要
Background: The availability of vaccines provides a promising solution to contain the COVID-19 pandemic. However,it remains unclear whether the large-scale vaccination can succeed in containing the COVID-19 pandemic and how soon. We developed an epidemiological model named SUVQC(Suceptible-Unquarantined-Vaccined-QuarantinedConfirmed) to quantitatively analyze and predict the epidemic dynamics of COVID-19 under vaccination.Methods: In addition to the impact of non-pharmaceutical interventions(NPIs), our model explicitly parameterizes key factors related to vaccination, including the duration of immunity, vaccine efficacy, and daily vaccination rate etc.The model was applied to the daily reported numbers of confirmed cases of Israel and the USA to explore and predict trends under vaccination based on their current epidemic statuses and intervention measures. We further provided a formula for designing a practical vaccination strategy, which simultaneously considers the effects of the basic reproductive number of COVID-19, intensity of NPIs, duration of immunological memory after vaccination, vaccine efficacy and daily vaccination rate.Results: In Israel, 53.83% of the population is fully vaccinated, and under the current NPI intensity and vaccination scheme, the pandemic is predicted to end between May 14, 2021, and May 16, 2021, assuming immunity persists for180 days to 365 days. If NPIs are not implemented after March 24, 2021, the pandemic will end later, between July 4,2021, and August 26, 2021. For the USA, if we assume the current vaccination rate(0.268% per day) and intensity of NPIs, the pandemic will end between January 20, 2022, and October 19, 2024, assuming immunity persists for 180days to 365 days. However, assuming immunity persists for 180 days and no NPIs are implemented, the pandemic will not end and instead reach an equilibrium state, with a proportion of the population remaining actively infected.Conclusions: Overall, the daily vaccination rate should be decided according to vaccine efficacy and immunity duration to achieve herd immunity. In some situations, vaccination alone cannot stop the pandemic, and NPIs are necessary to supplement vaccination and accelerate the end of the pandemic. Considering that vaccine efficacy and duration of immunity may be reduced for new mutant strains, it is necessary to remain cautiously optimistic about the prospect of ending the pandemic under vaccination.
引用
收藏
页码:304 / 316
页数:13
相关论文
共 50 条
  • [21] Hesitancy of Arab Healthcare Workers towards COVID-19 Vaccination: A Large-Scale Multinational Study
    Qunaibi, Eyad
    Basheti, Iman
    Soudy, Mohamed
    Sultan, Iyad
    VACCINES, 2021, 9 (05)
  • [22] Vaccination effects on reducing COVID-19 complications in pregnancy: A large-scale report from Iran
    Changizi, Nasrin
    Eshrati, Babak
    Salehi, Mohammadreza
    Beheshtian, Maryam
    Hadipour Jahromy, Leila
    Emami Afshar, Nehzat
    Hejazi, Saeideh
    Hantoushzadeh, Sedigheh
    Eslamian, Laleh
    Savaie, Mohsen
    Raeisi, Alireza
    Pooransari, Parichehr
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2023, 163 (03) : 1012 - 1017
  • [23] Optimizing Signal Detection for Large Scale COVID-19 Vaccination
    Van Hunsel, F.
    Oosterhuis, I.
    van Puijenbroek, E.
    DRUG SAFETY, 2021, 44 (12) : 1416 - 1417
  • [24] Evolution of Public Opinion on COVID-19 Vaccination in Japan: Large-Scale Twitter Data Analysis
    Kobayashi, Ryota
    Takedomi, Yuka
    Nakayama, Yuri
    Suda, Towa
    Uno, Takeaki
    Hashimoto, Takako
    Toyoda, Masashi
    Yoshinaga, Naoki
    Kitsuregawa, Masaru
    Rocha, Luis E. C.
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2022, 24 (12)
  • [25] GROUP TESTING FOR LARGE-SCALE COVID-19 SCREENING
    Zahrouni, Wassim
    Kamoun, Hichem
    JOURNAL OF DECISION SYSTEMS, 2022, 32 (01) : 162 - 176
  • [26] Vaccination during the COVID-19 pandemic
    Danchin, Margie
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2020, 49 (10) : 621 - 621
  • [27] Vaccination in the context of the COVID-19 pandemic
    Diaz-Badillo, Alvaro
    Garibay-Nieto, Guadalupe N.
    Navas-Figueroa, Ana L.
    Perales-Torres, Adriana L.
    Concepcion Morales-Gomez, Maria
    Lopez-Alvarenga, Juan C.
    CIRUGIA Y CIRUJANOS, 2021, 89 (06): : 836 - 843
  • [28] COVID-19 Pandemic and Vaccination Skepticism
    Anas, Abdul Latif
    Salifu, Mashudu
    Zakaria, Hanan Lassen
    HUMAN ARENAS, 2023,
  • [29] Vaccination during the COVID-19 pandemic: how to address the complexity of the phenomenon?
    Caycho-Rodriguez, Tomas
    Gallegos, Miguel
    CIRUGIA Y CIRUJANOS, 2022, 90 (06): : 860 - 861
  • [30] Publisher Correction: The effect of large-scale anti-contagion policies on the COVID-19 pandemic
    Solomon Hsiang
    Daniel Allen
    Sébastien Annan-Phan
    Kendon Bell
    Ian Bolliger
    Trinetta Chong
    Hannah Druckenmiller
    Luna Yue Huang
    Andrew Hultgren
    Emma Krasovich
    Peiley Lau
    Jaecheol Lee
    Esther Rolf
    Jeanette Tseng
    Tiffany Wu
    Nature, 2020, 585 (7824) : E7 - E7